Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target
Crossref DOI link: https://doi.org/10.1038/s41401-020-00557-5
Published Online: 2020-11-19
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xin
Hu, Can
Wu, Hai-ming
Ma, Zhen-guo
Tang, Qi-zhu
Text and Data Mining valid from 2020-11-19
Version of Record valid from 2020-11-19
Article History
Received: 4 August 2020
Accepted: 13 October 2020
First Online: 19 November 2020
Conflict of interest
: The authors declare that they have no conflict of interest.